- In Memoriam: L. Penfield Faber, MD (October 30, 1931-June 32026, ). [Journal Article]Ann Thorac Surg. 2026 Aug 06. [Online ahead of print]AT
- Leroy Penfield Faber, MD recently passed at the age of 97 years old. He was a master educator, an early proponent of multidisciplinary cancer care, and instrumental in developing flexile bronchoscopy, stapled bronchial closure, and segmental lung resections for cancer. Dr. Faber leaves behind a specialty that bears his imprint at many levels: in its culture, its standards, its leadership, and in …
- Publisher Full Text (DOI)
- A NEW ERA FOR THE SURGICAL TREATMENT OF ATRIAL FIBRILLATION: EVOLVING SURGICAL TECHNIQUES AND CLINICAL CONSIDERATIONS. [Review]Ann Thorac Surg. 2026 Aug 06. [Online ahead of print]AT
- The fundamentals of effective surgical treatment for atrial fibrillation were established over 30 years ago with the development of the Cox-Maze operation. Restoration of atrioventricular synchrony, reduction of thromboembolic stroke risk, and symptom relief have always been the primary goals of therapy. Over time, surgical techniques and clinical considerations have significantly evolved, reachi…
- Publisher Full Text (DOI)
- Transcatheter versus Surgical Mitral Repair in Younger Patients: Experience and Patient-Centered Outcomes Matter. [Letter]Ann Thorac Surg. 2026 Aug 05. [Online ahead of print]AT
- Publisher Full Text (DOI)
- Reducing sternal wound infections after cardiac surgery through targeted, interdisciplinary efforts: A large, single-center experience. [Journal Article]Ann Thorac Surg. 2026 Aug 05. [Online ahead of print]AT
- CONCLUSIONS: Implementation of a SWI prevention bundle significantly reduced deep SWIs and associated readmissions. The relative increase in fungal infections highlights the need for targeted strategies against Candida species.
- Publisher Full Text (DOI)
- Bridge or Burden? Heart Transplant Outcomes Following Left Ventricular Assist Device Explant in the Contemporary Allocation Era. [Journal Article]Ann Thorac Surg. 2026 Aug 05. [Online ahead of print]AT
- CONCLUSIONS: LVAD explant during heart transplant was associated with greater transfusions, vasoplegia, and early-to-intermediate mortality compared with primary sternotomy. These findings suggest LVAD explant identifies a higher-risk transplant phenotype shaped by surgical burden, device-associated physiologic effects, and allocation-era transplant timing, rather than by intrinsic device-related risk alone.
- Publisher Full Text (DOI)
- Dropout after Neoadjuvant Chemoimmunotherapy for Non-Small Cell Lung Cancer in the Veterans Health Administration. [Journal Article]Ann Thorac Surg. 2026 Aug 05. [Online ahead of print]AT
- CONCLUSIONS: In our nationally representative cohort, patients undergoing chemoimmunotherapy with intent for surgical resection had favorable intermediate-term survival. however, nearly one-third of patients did not undergo surgery, most commonly due to disease progression. These findings highlight the need to better identify patients who do not progress to resection and define management strategies for these patients.
- Publisher Full Text (DOI)
- From Perception to Clinical Utility: Artificial Intelligence in Thoracic Surgery. [Letter]Ann Thorac Surg. 2026 Aug 05. [Online ahead of print]AT
- Publisher Full Text (DOI)
- The quest for the "holy grail" for classification of type A aortic dissection is just started! [Journal Article]Ann Thorac Surg. 2026 Aug 05. [Online ahead of print]AT
- Publisher Full Text (DOI)
- Beyond the Procedure: Unpacking Confounders in Reoperative Mitral Surgery versus Valve-in-Valve. [Letter]Ann Thorac Surg. 2026 Aug 05. [Online ahead of print]AT
- Publisher Full Text (DOI)
- CHIO3: CHemotherapy Combined with Immune Checkpoint Inhibitor for Operable Stage IIIA/B (N2) Non-Small Cell Lung Cancer: Surgical Outcomes. [Journal Article]Ann Thorac Surg. 2026 Aug 05. [Online ahead of print]AT
- CONCLUSIONS: This trial provides insight into surgical outcomes for prospectively documented N2+ NSCLC treated with neoadjuvant ChIO. Surgery in this challenging scenario was accomplished with no mortality, high rates of minimally invasive surgery, R0 resection, and lobectomy, with prompt return to oncologic therapy. Following ChIO, resection of N2+ NSCLC can be achieved with excellent outcomes and warrants stronger consideration within multidisciplinary NSCLC care.
- Publisher Full Text (DOI)
- Beyond the Pack-Year: The Missing Pedigree. [Journal Article]Ann Thorac Surg. 2026 Aug 05. [Online ahead of print]AT
- Publisher Full Text (DOI)
- Surgical progress in pediatric mitral valve disease. [Journal Article]Ann Thorac Surg. 2026 Aug 05. [Online ahead of print]AT
- Publisher Full Text (DOI)
- Understanding the Role of Extracorporeal Membrane Oxygenation Support in Patients With Ischemic Ventricular Septal Defect. [Letter]Ann Thorac Surg. 2026 Aug 04. [Online ahead of print]AT
- Publisher Full Text (DOI)
- Going with the Flow: How Pulmonary Artery Flow Restrictors Reset the Clock on Timing of Neonatal Operative Repair. [Journal Article]Ann Thorac Surg. 2026 Aug 04. [Online ahead of print]AT
- Publisher Full Text (DOI)
- When Support Becomes Strategy. [Journal Article]Ann Thorac Surg. 2026 Aug 05. [Online ahead of print]AT
- Publisher Full Text (DOI)